About MedinCell S.A.

Company Description

MedinCell® is a pharmaceutical company at premarketing stage that develops innovative long-acting injectable medicines in many therapeutic areas. Products of our portfolio are based on our BEPO® technology and aim to ensure patient compliance, improve the effectiveness and accessibility of treatments, and reduce their environmental footprint. We collaborate with tier one pharmaceuticals companies and foundations to improve Global Health through new therapeutic options.

Year founded

2003

Served area

Worldwide

Headcount

147

Headquarters

3 Rue des Frères Lumière, 34380 Jacou – France

Shareholder information

Shares outstanding

25,143,553

IPO

Oct. 8, 2018

Stock exchange(s)

Euronext Paris

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.